Back to results
US 2022/0031611 A1Published application
Immunosuppressive dosage forms and methods of use
AssigneeGemini Laboratories, LLC
InventorsPadam Bansal, Hardik Patel, Amitkumar Patel, Suhaskumar Patel
Life of this patent
Estimating the term…
Abstract
The present disclosure relates to formulations, methods, kits, and dosage forms for oral pharmaceutical formulations comprising one or more immunosuppressive agents. The pharmaceutical formulations of the present disclosure can be useful in treating organ or stem cell transplant recipients or T-cell mediated diseases.
Claims12
An oral liquid dosage formulation comprising:
- (a) one or more immunosuppressive agents;
- (b) one or more pharmaceutically acceptable solubilizers;
- and
- (c) optionally one or more pharmaceutically acceptable excipients selected from the group consisting of flavoring agents, sweeteners, preservatives, buffering agents, pH adjusting agents, dispersants, carriers or combinations thereof wherein the formulation is a non-aqueous solution.
1 more element
An oral liquid dosage formulation comprising:
- (a) tacrolimus;
- (b) one or more pharmaceutically acceptable solubilizers selected from the group consisting of selected from the group consisting of polyethylene glycols, propylene glycol, glycerin, triacetin, ethanol, polysorbates, oils and combinations thereof;
- and
- (c) optionally one or more pharmaceutically acceptable excipients selected from the group consisting of flavoring agents, sweeteners, preservatives, buffering agents, pH adjusting agents, or combinations thereof wherein the formulation is a non-aqueous solution, free of a surfactant, wetting agent, emulsifying agent and low molecular weight mono alcohols.
1 more element
Dependencies are inferred from the claim text.